The Trulieve Cannabis Corp. (CSE:TRUL) share price has softened a substantial 29% over the previous 30 days, handing back much of the gains the stock has made lately. Instead of being rewarded, shareholders who have already held through the last twelve months are now sitting on a 18% share price drop.
Even after such a large drop in price, you could still be forgiven for feeling indifferent about Trulieve Cannabis’ P/S ratio of 1x, since the median price-to-sales (or “P/S”) ratio for the Pharmaceuticals industry in Canada is also close to 0.9x. However, investors might be overlooking a clear opportunity or potential setback if there is no rational basis for the P/S.
View our latest analysis for Trulieve Cannabis
